SEARCH

SEARCH BY CITATION

References

  • 1
    Biological products: allergenic extracts: implementation of efficacy review. Federal register, food and drug administration. 1985; 21 CRF Parts 600, 610 and 680 (Docket no. 81N-0096)
  • 2
    Desbordes J. The need for standardization of allergenic products utilized in humans for diagnosis and therapy. Dev Biol Stand 1975;29:267275.
  • 3
    Lichtenstein LM. Standardization and efficacy of allergen products. N Engl J Med 1976;295:11951196.
  • 4
    Baer H. Standardization of antigens. J Allergy Clin Immunol 1978;61:206208.
  • 5
    Yunginger JW, Squillace DM, Helm RM. IUIS criteria for reference preparations. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1988;82:129135.
  • 6
    Dreborg S, Frew A. Allergen standardization and skin tests. EAACI Position Paper. Allergy 1993;48(Suppl. 14):4982.
  • 7
    The use of standardized allergen extracts. Position Statement.American Academy of Allergy, Asthma and Immunology (AAAAI). J Allergy Clin Immunol 1997;99:583586.
  • 8
    Sjoholm I. Standardization of allergens in Europe. Arb Paul Ehrlich Institut 1997;91:107110.
  • 9
    Maasch HJ, Wahl R. Preparation of human serum pools for allergen specific IgE: criteria for selection and reproducibility. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1988;82:117127.
  • 10
    Rules governing medical products in the European Community. Vol. III. Note for guidance on allergen productsCPMP/BWP/243/96, 1991.
  • 11
    Nordic Council on Medicines. Registration of allergenic preparations. Nordic Guidelines. 2nd  edn Uppsala: NLN Publications No. 23, 1989:134.
  • 12
    Carreira J, Lombardero M, Ventas P. New developments in in vitro methods. Quantification of clinically relevant allergens in mass units. Arb Paul Ehrlich Institut 1994;87:155166.
  • 13
    BousquetJ, LockeyRF, MallingH-J (Eds). Allergen immunotherapy: therapeutic vaccines for allergic diseases. WHO position paper. Allergy 1998;53(Suppl.):142.
  • 14
    Nelson HS. The use of standardized extracts in allergen immunotherapy. J Allergy Clin Immunol 2000;106:4145.
  • 15
    Marsh DG, Lichtenstein LM, Campbell DH. Studies on ‘‘allergoids’’ prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology 1970;18:705722.
  • 16
    Marsh DG, Norman PS, Roebber M, Lichtenstein LM. Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 1981;68:449459.
  • 17
    Weeke B, Weeke E, Løwenstein H. The adsorption of serum proteins to aluminium hydroxide gel examined by means of quantitative immunoelectrophoresis. In: AxelsenNH, editor. Quantitative immunoelectrophoresis, new development and applications. Scan J Immunol 1975;4(Suppl. 2):149154.
  • 18
    Niederberger V, Valenta R. Recombinant allergens for immunotherapy. Where do we stand? Curr Opin Allergy Clin Immunol 2004;4:549554.